BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 15494719)

  • 21. MUC1 and MUC2 in pancreatic neoplasia.
    Levi E; Klimstra DS; Andea A; Basturk O; Adsay NV
    J Clin Pathol; 2004 May; 57(5):456-62. PubMed ID: 15113850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling).
    Hanson RL; Hollingsworth MA
    Biomolecules; 2016 Jul; 6(3):. PubMed ID: 27483328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity of high-molecular-weight human salivary mucins.
    Offner GD; Troxler RF
    Adv Dent Res; 2000 Dec; 14():69-75. PubMed ID: 11842927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of membrane-bound mucins (MUC1 and MUC4) and secreted mucins (MUC2, MUC5AC, MUC5B, MUC6 and MUC7) in mucoepidermoid carcinomas of salivary glands.
    Alos L; Lujan B; Castillo M; Nadal A; Carreras M; Caballero M; de Bolos C; Cardesa A
    Am J Surg Pathol; 2005 Jun; 29(6):806-13. PubMed ID: 15897748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of MUC1, MUC2, MUC3 and MUC4 mucin mRNAs in human pancreatic and intestinal tumor cell lines.
    Hollingsworth MA; Strawhecker JM; Caffrey TC; Mack DR
    Int J Cancer; 1994 Apr; 57(2):198-203. PubMed ID: 8157358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of mucin expression: mechanistic aspects and implications for cancer and inflammatory diseases.
    Andrianifahanana M; Moniaux N; Batra SK
    Biochim Biophys Acta; 2006 Apr; 1765(2):189-222. PubMed ID: 16487661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of sialyl-Lewis x on MUC5AC and MUC1 mucins in pancreatic cancer tissues.
    Balmaña M; Duran A; Gomes C; Llop E; López-Martos R; Ortiz MR; Barrabés S; Reis CA; Peracaula R
    Int J Biol Macromol; 2018 Jun; 112():33-45. PubMed ID: 29408556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mucin-based targeted pancreatic cancer therapy.
    Torres MP; Chakraborty S; Souchek J; Batra SK
    Curr Pharm Des; 2012; 18(17):2472-81. PubMed ID: 22372499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances on the molecular mechanisms involved in pancreatic cancer progression and therapies.
    Mimeault M; Brand RE; Sasson AA; Batra SK
    Pancreas; 2005 Nov; 31(4):301-16. PubMed ID: 16258363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human fetal ductal plate revisited: II. MUC1, MUC5AC, and MUC6 are expressed in human fetal ductal plate and MUC1 is expressed also in remodeling ductal plate, remodeled ductal plate and mature bile ducts of human fetal livers.
    Terada T
    Int J Clin Exp Pathol; 2013; 6(4):571-85. PubMed ID: 23573304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic value of mucins (MUC1, MUC2 and MUC5AC) expression profile in endoscopic ultrasound-guided fine-needle aspiration specimens of the pancreas.
    Wang Y; Gao J; Li Z; Jin Z; Gong Y; Man X
    Int J Cancer; 2007 Dec; 121(12):2716-22. PubMed ID: 17708554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serological pancreatic tumor markers and the MUC1 apomucin.
    Ho JJ; Kim YS
    Pancreas; 1994 Nov; 9(6):674-91. PubMed ID: 7846010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigating the role of mucin in the delivery of nanoparticles to cellular models of human cancer disease: an in vitro study.
    Alkholief M; Campbell RB
    Nanomedicine; 2016 Jul; 12(5):1291-302. PubMed ID: 26961466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered expression of transmembrane mucins, MUC1 and MUC4, in bladder cancer: pathological implications in diagnosis.
    Kaur S; Momi N; Chakraborty S; Wagner DG; Horn AJ; Lele SM; Theodorescu D; Batra SK
    PLoS One; 2014; 9(3):e92742. PubMed ID: 24671186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration.
    Chhieng DC; Benson E; Eltoum I; Eloubeidi MA; Jhala N; Jhala D; Siegal GP; Grizzle WE; Manne U
    Cancer; 2003 Dec; 99(6):365-71. PubMed ID: 14681945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas.
    Kim GE; Bae HI; Park HU; Kuan SF; Crawley SC; Ho JJ; Kim YS
    Gastroenterology; 2002 Oct; 123(4):1052-60. PubMed ID: 12360467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression profiles of MUC1, MUC2, and MUC4 mucins in human neoplasms and their relationship with biological behavior.
    Yonezawa S; Goto M; Yamada N; Higashi M; Nomoto M
    Proteomics; 2008 Aug; 8(16):3329-41. PubMed ID: 18651706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions.
    Terris B; Dubois S; Buisine MP; Sauvanet A; Ruszniewski P; Aubert JP; Porchet N; Couvelard A; Degott C; Fléjou JF
    J Pathol; 2002 Aug; 197(5):632-7. PubMed ID: 12210083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucin glycosylation is altered by pro-inflammatory signaling in pancreatic-cancer cells.
    Wu YM; Nowack DD; Omenn GS; Haab BB
    J Proteome Res; 2009 Apr; 8(4):1876-86. PubMed ID: 19714813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucins in the diagnosis and therapy of pancreatic cancer.
    Ho JJ
    Curr Pharm Des; 2000 Dec; 6(18):1881-96. PubMed ID: 11102566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.